Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Right Ventricular Function
100%
Angiotensin II Type 1 Receptor (AT1R)
100%
Receptor Antagonism
100%
Angiotensin Receptor-neprilysin Inhibitor
100%
LCZ696
100%
Experimental Pulmonary Hypertension
100%
Pulmonary Hypertension
42%
Hypoxia
28%
Right Ventricular Hypertrophy
28%
Right Ventricular Systolic Pressure
28%
Pulmonary Artery Banding
28%
SU5416
28%
Therapeutic Potential
14%
Hypertrophy
14%
Vascular Endothelial Growth Factor
14%
Dilatation
14%
Wall Thickness
14%
Cyclic GMP
14%
Heart Failure Patients
14%
Receptor Antagonist
14%
Right Ventricular Dilatation
14%
Pulmonary Artery
14%
Pulmonary Vascular
14%
Pulmonary Vascular Remodeling
14%
Cardiac Effects
14%
Combined Exposure
14%
Pulmonary Vascular Changes
14%
Pulmonary Hypertension Treatment
14%
Medicine and Dentistry
Heart Right Ventricle Failure
100%
Angiotensin Receptor
100%
Neprilysin
100%
Experimental Pulmonary Hypertension
100%
Sacubitril Plus Valsartan
100%
Pulmonary Hypertension
57%
Hypoxia
28%
Right Ventricular Hypertrophy
28%
Semaxanib
28%
Trunk
28%
Congestive Heart Failure
14%
Pulmonary Artery
14%
Systolic Blood Pressure
14%
Cyclic GMP
14%
Heart Right Ventricle Pressure
14%
Heart Ventricle Function
14%
Heart Right Ventricle Function
14%
Receptor Antagonist
14%
Vasculotropin Receptor
14%
Morbidity
14%